Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 15, Number 9, March 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Editorial:[Hot Topic: The Role of Radiopharmaceuticals in Drug Discovery and Development(Executive Editor: Kalevi Kairemo)]
pp. 926-927(2)
Author: Kairemo, Kalevi

Microdosing, Imaging Biomarkers and SPECT: A Multi-Sided Tripod to Accelerate Drug Development
pp. 928-934(7)
Authors: Pauwels, Ernest K.J.; Bergstrom, Kim; Mariani, Giuliano; Kairemo, Kalevi

Cardiovascular Drug Development Using Radiopharmaceuticals
pp. 935-942(8)
Authors: Ukkonen, Heikki; Yoshinaga, Keiichiro; DaSilva, Jean N.; Beanlands, Rob S.B.; Knuuti, Juhani

Role of Radiopharmaceuticals in Development of Inhaled Drugs
pp. 943-949(7)
Author: Jekunen, Antti P.

Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
pp. 950-956(7)
Author: Larson, Steven M.

Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
pp. 957-965(9)
Authors: Murphy, Philip S.; Bergstrom, Mats

Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
pp. 966-982(17)
Author: Turner, J. H.

Cancer Drug Development Using Glucose Metabolism Radiopharmaceuticals
pp. 983-987(5)
Authors: Sun, Y. Y.; Chen, Y.

Development of a PBPK Model for Monoclonal Antibodies and Simulation of Human and Mice PBPK of a Radiolabelled Monoclonal Antibody
pp. 988-1007(20)
Authors: Heiskanen, Tomi; Heiskanen, Tomas; Kairemo, Kalevi

Vanilloid Receptor Antagonists: Emerging Class of Novel Anti-Inflammatory Agents for Pain Management
pp. 1008-1026(19)
Authors: Pal, Manojit; Angaru, Sowjanya; Kodimuthali, Arumugam; Dhingra, Nidhi

Atheroprotective Properties of Pigment Epithelium-Derived Factor (PEDF) in Cardiometabolic Disorders
pp. 1027-1033(7)
Authors: Yamagishi, Sho-ichi; Matsui, Takanori; Nakamura, Kazuo

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A